Quarterly report pursuant to Section 13 or 15(d)

Revenue (Tables)

v3.24.1.u1
Revenue (Tables)
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregated Revenue by Product Line
Disaggregated revenue by product line and segment was as follows:

Three Months Ended March 31,
2024 2023
Passenger Segment
Short Distance
$ 9,810  $ 10,425 
Jet and Other 5,678  8,079 
Total $ 15,488  $ 18,504 
Medical Segment
MediMobility Organ Transport $ 36,026  $ 26,767 
Total $ 36,026  $ 26,767 
Total Revenue
$ 51,514  $ 45,271 
Rollforward of Contract Liability Balance
Three Months Ended March 31,
2024 2023
Balance, beginning of period $ 6,845  $ 6,709 
Additions 11,960  13,599 
Revenue recognized (10,824) (12,520)
Balance, end of period $ 7,981  $ 7,788